S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon

Propanc Biopharma (PPCB) Short Interest Ratio & Short Volume

$0.0011
0.00 (0.00%)
(As of 04/19/2024 ET)

Propanc Biopharma Short Interest Data

Current Short Volume
6,200 shares
Previous Short Volume
0 shares
Change Vs. Previous Month
+∞
Dollar Volume Sold Short
$19.84
Short Interest Ratio / Days to Cover
0.0
Last Record Date
March 31, 2024
Outstanding Shares
52,150,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
5,550,947 shares
Average Trading Volume
6,148,357 shares
Today's Volume Vs. Average
90%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Propanc Biopharma ?

Sign up to receive the latest short interest report for Propanc Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PPCB Short Interest Over Time

PPCB Days to Cover Over Time

PPCB Percentage of Float Shorted Over Time

Propanc Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20246,200 shares $19.84 No ChangeN/A0 $0.00
2/29/2024127,100 shares $432.14 +355.6%N/A0 $0.00
2/15/202427,900 shares $131.13 +39.5%N/A0 $0.00
1/15/202412,000 shares $120.00 +11,900.0%N/A0 $0.01
12/31/2023100 shares $1.20 -99.8%N/A0 $0.01
12/15/202359,300 shares $646.37 +352.7%N/A0 $0.01
11/30/202313,100 shares $111.35 +23.6%N/A0 $0.01
11/15/202310,600 shares $140.98 -74.9%N/A0 $0.01
10/31/202342,200 shares $481.08 +20.6%N/A0.1 $0.01
10/15/202335,000 shares $560.00 +18.2%N/A0 $0.02
9/30/202329,600 shares $722.24 +179.3%N/A0.1 $0.02
9/15/202310,600 shares $318.00 -64.7%N/A0 $0.03
8/31/202330,000 shares $1,647.00 No ChangeN/A0 $0.05
7/31/202334,000 shares $2,764.20 -5.0%N/A0 $0.08
7/15/202335,800 shares $3,377.73 +21.8%N/A0 $0.09
6/30/202329,400 shares $3,969.00 No ChangeN/A0 $0.14
5/15/2023310,100 shares $62,020.00 +310,000.0%N/A0 $0.20
4/30/2023100 shares $0.03 -99.5%N/A0 $0.00
4/15/202318,100 shares $5.43 -90.4%N/A0 $0.00
3/31/2023188,600 shares $94.30 +887.4%N/A0 $0.00
3/15/202319,100 shares $11.46 -39.2%N/A0 $0.00
2/28/202331,400 shares $21.98 -7.9%N/A0 $0.00
2/15/202334,100 shares $10.23 -76.3%N/A0 $0.00
1/31/2023144,000 shares $57.60 -28.0%N/A0 $0.00
1/15/2023200,100 shares $100.05 +200,000.0%N/A0 $0.00
12/30/2022100 shares $0.06 -99.8%N/A0 $0.00
12/15/202255,100 shares $33.06 -90.3%N/A0 $0.00
11/30/2022565,200 shares $395.64 +1,025.9%N/A0 $0.00
11/15/202250,200 shares $40.16 -49.9%N/A0 $0.00
10/31/2022100,200 shares $100.20 +57.8%N/A0 $0.00
10/15/202263,500 shares $76.20 -30.6%N/A0 $0.00
9/30/202291,500 shares $109.80 +45,650.0%N/A0 $0.00
9/15/2022200 shares $0.34 -99.3%N/A0 $0.00
8/31/202228,500 shares $54.15 -78.2%N/A0 $0.00
8/15/2022130,800 shares $300.84 +8.0%N/A0 $0.00
7/31/2022121,100 shares $399.63 -47.4%N/A0 $0.00
7/15/2022230,000 shares $575.00 +37.6%N/A0 $0.00
6/30/2022167,200 shares $618.64 +113.3%N/A0 $0.00
6/15/202278,400 shares $227.36 +27.7%N/A0 $0.00
5/31/202261,400 shares $466.64 +1,103.9%N/A0 $0.01
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

PPCB Short Interest - Frequently Asked Questions

What is Propanc Biopharma's current short interest?

Short interest is the volume of Propanc Biopharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 6,200 shares of PPCB short. Learn More on Propanc Biopharma's current short interest.

Is Propanc Biopharma's short interest increasing or decreasing?

Propanc Biopharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 6,200 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Propanc Biopharma's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Propanc Biopharma: Amarantus BioScience Holdings, Inc. (0.00%), Adhera Therapeutics, Inc. (0.00%), Predictive Technology Group, Inc. (0.00%), Acura Pharmaceuticals, Inc. (0.01%), GelStat Corp. (0.00%), Oncology Pharma Inc. (0.03%), Todos Medical Ltd. (0.07%), Bruush Oral Care Inc. (62.06%), and Avivagen Inc. (0.03%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Propanc Biopharma stock?

Short selling PPCB is an investing strategy that aims to generate trading profit from Propanc Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Propanc Biopharma?

A short squeeze for Propanc Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPCB, which in turn drives the price of the stock up even further.

How often is Propanc Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPCB, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:PPCB) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners